Search
Showing results for "Study of bullying"
We were delighted to have Australia’s best-known parenting author, Maggie Dent, back at The Kids Research Institute Australia this week, to talk about the mental health of our teenagers.
Sepsis is a significant cause of mortality for children in Australia, particularly affecting young children, those with pre-existing health conditions and Aboriginal and Torres Strait Islander populations. The transition from hospital to home can be challenging for survivors, often leaving long-term impacts unaddressed.
Whooping Cough Day in 2025 has a special significance to Catherine Hughes AM and her family - it marks a decade of dedication to vaccine advocacy after the loss of their four-week-old baby son Riley in 2015.
Cancer researchers have narrowed-down the field of immunotherapy drugs which could be used to tackle a form of childhood brain cancer.
Find out what our communities had to say about the draft Statement on Consumers and Community Involvement in Health and Medical Research.
Respiratory disease is a leading cause of hospitalisations in children with cerebral palsy (CP). Over 40% of individuals with CP are born preterm; however, the relationship between prematurity, CP and respiratory disease is unknown.
Professor Andrew Whitehouse, who has helped transform clinical support for children on the autism spectrum in Australia, is nominated for WA's 2023 Australian of the Year.
Western Australia’s biggest and only medical research institute dedicated to improving kids’ health and wellbeing has rebranded to The Kids Research Institute Australia.
As herpes simplex virus in infancy is not a mandatory notifiable condition in Australia, completeness of ascertainment by the Australian Paediatric Surveillance Unit (APSU) has been difficult to evaluate to date. We evaluated case capture in Queensland and Western Australia using statewide laboratory and clinical data and complementary surveillance data collected via the APSU.
Invasive fungal disease (IFD) remains a common and serious complication in children treated for leukaemia. Antifungal prescription in children with leukaemia presents unique challenges, particularly due to variation in IFD risk between and within leukaemia treatment protocols, drug toxicities and interactions between antifungals and chemotherapeutic agents.